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Abstract 
This study aims to explore irregular relationships between input and outcomes in cost-effectiveness analysis, accounting for 
interdependencies between many input parameters. We used a dynamic infectious disease transmission model investigating the 
cost-effectiveness of varicella and zoster vaccination as a case study.  Incremental costs and effects were used separately as the 
outcomes of interest, rather than the ratio between these, and a single R² was calculated for groups of interdependent input 
parameters. Partial R² was obtained as measure for the marginal proportion of variance explained. The most important input 
parameters were related to zoster epidemiology and disease transmission. In case of linear relationships, R² is an easy to obtain 
importance measure, also in the presence of interdependent input parameters. 
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1. Main text  
Background: Thorough sensitivity analyses exploring to which degree each input parameter contributes to the 
dispersion of outcomes are rarely made in health economic evaluations. In such analyses two problems may arise: 
(1) the relationship between input and outcome (the Incremental Cost Effectiveness Ratio (ICER) = incremental 
costs/Incremental Quality Adjusted Life Years (QALYs)) is non-linear and non-monotone because the ICER is a 
ratio, and (2) several groups of input parameters are strongly interdependent.  
Aim: We aim to explore the above problems in the context of a cost-effectiveness analysis of childhood varicella 
vaccination combined with adult zoster vaccination in England&Wales. In this analysis 185 input parameters were 
modeled to obtain outcomes mainly in terms of incremental costs, incremental QALYs, and the outcome of interest 
for policy making, the ICER. The uncertainty of each of these parameters was represented by distributions, and 
propagated into these outcomes using Monte Carlo simulation (van Hoek et al, 2010). 
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Methods:  
1) Dealing with non-linearity and non-monotonicity - Due to the non-linear and non-monotone relationship 
between the ICER and the input parameters, obtaining importance measures is not straightforward from a statistical 
point of view. Also, the interpretation of the ICER depends on the signs of both denominator and numerator 
separately. To overcome both statistical and interpretation problems, importance measures are obtained for 
incremental costs and QALY’s separately. As measure for importance, the coefficient of determination (R²) from a 
regression analysis for each input parameter is used (Briggs et al 2006). R² measures how much of the variance in 
the outcome is explained by a linear relation with that input parameter. Assumptions of linearity and normality of 
residuals for these regression analyses are checked.  
2) Dealing with (many) interdependent input parameters –100 parameters (=10*10) describe the probabilities to 
transmit the disease from each of 10 different age groups to each of 10 different age groups. These 100 transmission 
parameters are interdependent because they are estimated using a single model and dataset, and therefore a single R² 
is obtained for this group (Briggs et al 2006). For the same reason, a single R² is obtained for 2 parameters 
describing vaccine efficacy, i.e. “take” and “waning”. A single R² is also obtained for parameter ‘delta’ (the rate by 
which 'boosted' individuals become susceptible to zoster again) and parameter ‘chi’ (the reduction in zoster 
reactivation in vaccinees versus non-vaccinees), because the chi parameter is partially based on the delta parameter. 
Additionally, partial R²’s are obtained for the individual parameters belonging to these interdependent groups. 
Partial R² measures the marginal contribution of a parameter when all other parameters are in the model. It is similar 
to what Xu & Gertner (2008) call the 'uncorrelated' proportion of variance in the outcome explained.  
Results: A linear model with all input parameters (main effects only) approximates well the relationship between 
input parameters and incremental costs and incremental QALY's (coefficient of determination R²=0.92 and 0.87 
respectively). Residuals are normally distributed (Shapiro-Wilk normality test, W>0.95). 
Chi and delta together, and the groups of transmission parameters explain 62% and 28% of the variance in 
incremental costs, and 47% and 29% of the variance in incremental QALY’s, respectively. Zoster vaccine take and 
waning explain 4% of the variance in incremental costs and 11% of the variance in incremental QALY’s. All other 
parameters explain less than 1% of the variance in incremental costs and QALY’s. 
Marginal contributions of chi and delta are 38% and 27% to incremental costs, and 19% and 30% to incremental 
QALY’s, respectively. Among the transmission parameters, the marginal contributions to the incremental costs are 
the highest for the parameters describing transmission between children below 4 years of age (partial R²’s are 
between 1% and 3%). The marginal contributions of the transmission parameters to incremental QALY’s all lie 
below 0.1%.  
Discussion: In case of linear relationships, (partial) R² is an easy to obtain importance measure, also in presence 
of interdependent input. This study shows that a complex health economic model for varicella and zoster 
vaccination can be approximated by a simple linear regression model (R²=0.9). Also, assessing the importance of 
input parameters serves as an internal model check (Saltelli et al 2008). One of the limitations of this study is that 
only linear relationships and linear associations are taken into account. Assessing importance measures, especially in 
case of interdependent input, becomes more difficult when relationships become more irregular. Additionally, the 
importance measures given are conditional on methods, model characteristics, databases and parameter 
distributions. A future challenge would be to calculate the variance explained by each of the input parameters in an 
exact way instead of using a statistical approximation to the model. As the model is in fact completely known, this is 
mathematically possible but needs extensive calculations. 
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